NCT03638115 is a NA clinical trial of VaSecure™ in Peripheral Artery Disease, sponsored by Vascuros Medical Pte Ltd.

Who is sponsoring NCT03638115?

NCT03638115 is sponsored by Vascuros Medical Pte Ltd.

What drugs are being tested in NCT03638115?

Interventions in NCT03638115: VaSecure™.

What condition does NCT03638115 study?

NCT03638115 studies Peripheral Artery Disease, Peripheral Vascular Disease, Peripheral Arterial Occlusive Disease.

Is NCT03638115 still recruiting?

NCT03638115 is currently status unknown. Last updated 26 October 2018.

Last reviewed 2018-10-26 · How we verify

NCT03638115

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The VaSecure BTK Study

Status unknown NA Last updated 26 October 2018

What this trial tests

NA trial testing VaSecure™ in Peripheral Artery Disease in 46 participants. Status unknown.

Timeline

30 October 2018

Primary endpoint
1 June 2019

30 June 2020

Quick facts

Lead sponsor	Vascuros Medical Pte Ltd
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	46
Start date	30 October 2018
Primary completion	1 June 2019
Estimated completion	30 June 2020
Sites	7 locations across Belgium, Singapore, Germany

Drugs / interventions tested

VaSecure™

Conditions studied

Peripheral Artery Disease — all drugs for Peripheral Artery Disease →
Peripheral Vascular Disease — all drugs for Peripheral Vascular Disease →
Peripheral Arterial Occlusive Disease — all drugs for Peripheral Arterial Occlusive Disease →

Sponsor

Vascuros Medical Pte Ltd

Who can join

Adults 21 to 90, any sex, with Peripheral Artery Disease or Peripheral Vascular Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To assess the safety and performance of the VaSecure drug-coated PTA balloon catheter in the treatment of patients with Chronic Limb Threatening Ischemia (CLTI) of the lower limb below the knee (BTK)

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Peripheral Artery Disease

Currently open trials in the same condition.

NCT07374601 — The Value of Super-resolution Ultrasound Imaging for Peripheral Artery Disease · recruiting
NCT06686121 — Improving Mobility After Revascularization in Peripheral Artery Disease · Phase 3 · recruiting
NCT04433572 — Temsirolimus Adventitial Delivery to Improve ANGioplasty and/or Atherectomy Revascularization Outcomes Below the Knee · Phase 3 · recruiting
NCT06890208 — Chronical Illness-related Limitations of the Ability to Cope With Rising Temperatures, Third Wave · recruiting
NCT07012070 — Improving Walking Performance in Patients With Peripheral Artery Disease Through Wearable Activity Trackers · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03638115 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Vascuros Medical Pte Ltd
Last refreshed: 26 October 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03638115.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing